Robust risk committee is need of the hour: Dr Mazumdar-Shaw

Bangalore: Risk management should be seen as an opportunity and innovative approaches are required to address mission cr...

August 28, 2012 | Tuesday | Regulatory
Antibody R&D: What APAC firms are working on?

Over the years, some of the Asian companies have made significant breakthroughs in antibody research and are exploring f...

October 3, 2012 | Wednesday | Analysis
More pharma FDI proposals cleared by India

Singapore: Providing a final nod to 17 Foreign Direct Investment (FDI) proposals in India across various sectors, the co...

September 4, 2013 | Wednesday | News
Dr Saleem Mohammad, Xcode Lifesciences: DNA-based customized medical care on anvil

If you are unwell, you could visit a doctor, but no longer will you be taking general medication for a range of possible...

December 26, 2012 | Wednesday | Opinion
Sun Pharma settles Gleevec compound litigation

Singapore: Novartis Pharmaceuticals has reported to settle its litigation with US subsidiary of India based Sun Pharmace...

May 20, 2014 | Tuesday | Regulatory
Piramal Alzheimer's detector gets FDA, EMA nod

Singapore: The US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted Piramal Imagi...

March 22, 2013 | Friday | News
Pharmacovigilance: A strategic opportunity

For many Asian pharmaceutical companies, pharmacovigilance is a critical component of any drug development program. As p...

September 6, 2012 | Thursday | Opinion
Pfenex, Agila JV to develop biosimilar

Bangalore: US-based Pfenex and India-based Agila Biotech, a subsidiary of Strides Arcolab, entered into a joint venture ...

April 17, 2013 | Wednesday | News
Lack of collective voice hampers biosupplier sector

Started in 1999, India-based GenAxy Scientific with its corporate office in New Delhi and head office in Solan, has made...

February 28, 2013 | Thursday | Influencers
MNCs boost Asia biologics industry

Entry of multinational companies has been a big boost to Asia's position in biologics manufacturing, especially with cGM...

March 7, 2012 | Wednesday | News
Lupin gets FDA approval for Lyrica generic

Mumbai: Pharma major Lupin's subsidiary, Lupin Pharmaceuticals, has received final approval for its pregabalin capsules,...

July 6, 2012 | Friday | Regulatory
Bioagri inching towards saturation in India

The BioAgri sector has registered a record revenue of $621 million as compared to previous year's revenue of $140 millio...

August 6, 2012 | Monday | Analysis
LifeCell diversifies from cell banking to diagnostics, vaccine

LifeCell International, India's largest private stem cell bank and the first stem cell solution provider to bring the co...

December 31, 2012 | Monday | Influencers
Venus bags first patent from Canada for Vancoplus

New Delhi: Chandigarh-based Venus Remedies, a leading research based global pharmaceutical company secured its first pat...

September 12, 2012 | Wednesday | Regulatory
Indian state to slash prices of 348 drugs

Singapore: Tripura has become the first Indian state to announce its implementation of the country's health ministry's d...

July 23, 2013 | Tuesday | News
GVK licenses its biomarker database to National Cancer Institute

Singapore: GVK Biosciences, Asia's leading contract research organization (CRO) has licensed its popular clinical bioma...

September 7, 2012 | Friday | News
FDA to India: Regulatory compliance a must

Singapore: "Make quality the top priority," was the clear message from the FDA officials to Indian Pharma companies. A ...

May 14, 2014 | Wednesday | News
Projects under Indo-Australia Biotechnology Fund

...

May 18, 2012 | Friday | Analysis